TabletsMRP Under Process
Official PMBI MRP is being updated for catalog code 2843.
Locate Jan Aushadhi KendraClinical Overview
Opipramol is a tricyclic psychotropic agent that acts uniquely as a high-affinity sigma-1 and sigma-2 receptor agonist, with low-to-moderate affinity for dopamine D2, 5-HT2, and H1 receptors, and no monoamine reuptake inhibition. Produces prominent anxiolytic, calming, and somatic symptom-stabilizing effects. Indicated for generalized anxiety disorder (GAD) and somatoform disorders.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with or after meals with water, divided morning and evening, or as a single evening dose. Taper gradually before stopping.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Drowsiness, fatigue, dry mouth, dizziness, postural hypotension, mild stomach upset. Rare/Severe: Syncope, blood dyscrasias, liver function abnormalities, and cardiac arrhythmias.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in acute alcohol or hypnotic intoxication, urinary retention, and paralytic ileus. Caution in patients with cardiac conduction defects or benign prostatic hyperplasia. Avoid alcohol.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Camylofin Dihydrochloride 25mg + Paracetamol 300mg Tablets
Camylofin Dihydrochloride (25mg) and Paracetamol (300mg) Tablets is a fixed-dose antispasmodic and analgesic combination. Camylofin exerts a dual antispasmodic mechanism: antimuscarinic action and direct smooth muscle relaxation via phosphodiesterase inhibition, relieving visceral smooth muscle spasms in the gastrointestinal, biliary, and urinary tracts. Paracetamol provides centrally mediated pain relief. Indicated for severe visceral colic, intestinal colic, biliary colic, renal/ureteric colic, and painful spasmodic dysmenorrhea.
Opipramol Tablet (50 Mg)
Opipramol is a tricyclic psychotropic agent that acts uniquely as a high-affinity sigma-1 and sigma-2 receptor agonist, with low-to-moderate affinity for dopamine D2, 5-HT2, and H1 receptors, and no monoamine reuptake inhibition. Produces prominent anxiolytic, calming, and somatic symptom-stabilizing effects. Indicated for generalized anxiety disorder (GAD) and somatoform disorders.